Cancer and blood coagulation: molecular aspects.
Bromberg
M E
ME
Department of Internal Medicine, Yale University, School of Medicine, New Haven, Connecticut 06520, USA.
Cappello
M
M
D000970:Antineoplastic Agents / Q000494:pharmacology / Q000627:therapeutic use*; D001777:Blood Coagulation / Q000187:drug effects; D001779:Blood Coagulation Factors / Q000037:antagonists & inhibitors / Q000378:metabolism*; D015195:Drug Design; D015951:Factor Xa / Q000378:metabolism; D065427:Factor Xa Inhibitors; D006801:Humans; D009369:Neoplasms / Q000097:blood* / Q000188:drug therapy; D013917:Thrombin / Q000037:antagonists & inhibitors / Q000378:metabolism; D013925:Thromboplastin / Q000037:antagonists & inhibitors / Q000378:metabolism
D000970:Antineoplastic Agents; D001779:Blood Coagulation Factors; D065427:Factor Xa Inhibitors; D013925:Thromboplastin; D013917:Thrombin; D015951:Factor Xa